220 related articles for article (PubMed ID: 21921047)
1. Comprehensive analysis of tumor microenvironment cytokines in Waldenstrom macroglobulinemia identifies CCL5 as a novel modulator of IL-6 activity.
Elsawa SF; Novak AJ; Ziesmer SC; Almada LL; Hodge LS; Grote DM; Witzig TE; Fernandez-Zapico ME; Ansell SM
Blood; 2011 Nov; 118(20):5540-9. PubMed ID: 21921047
[TBL] [Abstract][Full Text] [Related]
2. IL-21 in the bone marrow microenvironment contributes to IgM secretion and proliferation of malignant cells in Waldenstrom macroglobulinemia.
Hodge LS; Ziesmer SC; Yang ZZ; Secreto FJ; Gertz MA; Novak AJ; Ansell SM
Blood; 2012 Nov; 120(18):3774-82. PubMed ID: 22976953
[TBL] [Abstract][Full Text] [Related]
3. [Cytokine profiles of multiple myeloma and Waldenström macroglobulinemia].
Sedlaříková L; Sadílková K; Kubiczková L; Hájek R; Sevčíková S
Klin Onkol; 2014; 27(1):18-23. PubMed ID: 24635433
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow microenvironment in Waldenstrom's Macroglobulinemia.
Jalali S; Ansell SM
Best Pract Res Clin Haematol; 2016 Jun; 29(2):148-155. PubMed ID: 27825460
[TBL] [Abstract][Full Text] [Related]
5. The Bone Marrow Microenvironment in Waldenström Macroglobulinemia.
Jalali S; Ansell SM
Hematol Oncol Clin North Am; 2018 Oct; 32(5):777-786. PubMed ID: 30190017
[TBL] [Abstract][Full Text] [Related]
6. Modulation of the IL-6 Receptor α Underlies GLI2-Mediated Regulation of Ig Secretion in Waldenström Macroglobulinemia Cells.
Jackson DA; Smith TD; Amarsaikhan N; Han W; Neil MS; Boi SK; Vrabel AM; Tolosa EJ; Almada LL; Fernandez-Zapico ME; Elsawa SF
J Immunol; 2015 Sep; 195(6):2908-16. PubMed ID: 26238488
[TBL] [Abstract][Full Text] [Related]
7. SDF-1/CXCR4 and VLA-4 interaction regulates homing in Waldenstrom macroglobulinemia.
Ngo HT; Leleu X; Lee J; Jia X; Melhem M; Runnels J; Moreau AS; Burwick N; Azab AK; Roccaro A; Azab F; Sacco A; Farag M; Sackstein R; Ghobrial IM
Blood; 2008 Jul; 112(1):150-8. PubMed ID: 18448868
[TBL] [Abstract][Full Text] [Related]
8. Soluble PD-1 ligands regulate T-cell function in Waldenstrom macroglobulinemia.
Jalali S; Price-Troska T; Paludo J; Villasboas J; Kim HJ; Yang ZZ; Novak AJ; Ansell SM
Blood Adv; 2018 Aug; 2(15):1985-1997. PubMed ID: 30104397
[TBL] [Abstract][Full Text] [Related]
9. Circulating Soluble Receptor Activator of Nuclear Factor Kappa B Ligand and C-C Motif Ligand 3 Correlate With Survival in Patients With Waldenström Macroglobulinemia.
Eleutherakis-Papaiakovou E; Kastritis E; Gavriatopoulou M; Christoulas D; Roussou M; Ntanasis-Stathopoulos I; Kanellias N; Papatheodorou A; Dimopoulos MA; Terpos E
Clin Lymphoma Myeloma Leuk; 2018 Jun; 18(6):431-437. PubMed ID: 29685422
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia promotes dissemination and colonization in new bone marrow niches in Waldenström macroglobulinemia.
Muz B; de la Puente P; Azab F; Ghobrial IM; Azab AK
Mol Cancer Res; 2015 Feb; 13(2):263-72. PubMed ID: 25232031
[TBL] [Abstract][Full Text] [Related]
11. Targeting the bone marrow in Waldenstrom macroglobulinemia.
Ghobrial IM; Zhang Y; Liu Y; Ngo H; Azab F; Sacco A; Azab A; Maiso P; Morgan B; Quang P; Issa GC; Leleu X; Roccaro AM
Clin Lymphoma Myeloma Leuk; 2011 Jun; 11 Suppl 1(Suppl 1):S65-9. PubMed ID: 22035751
[TBL] [Abstract][Full Text] [Related]
12. Cytokines in the microenvironment of Waldenström's macroglobulinemia.
Elsawa SF; Ansell SM
Clin Lymphoma Myeloma; 2009 Mar; 9(1):43-5. PubMed ID: 19362970
[TBL] [Abstract][Full Text] [Related]
13. B-lymphocyte stimulator (BLyS) stimulates immunoglobulin production and malignant B-cell growth in Waldenstrom macroglobulinemia.
Elsawa SF; Novak AJ; Grote DM; Ziesmer SC; Witzig TE; Kyle RA; Dillon SR; Harder B; Gross JA; Ansell SM
Blood; 2006 Apr; 107(7):2882-8. PubMed ID: 16304043
[TBL] [Abstract][Full Text] [Related]
14. The bone marrow microenvironment in Waldenström macroglobulinemia.
Agarwal A; Ghobrial IM
Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):218-21. PubMed ID: 23490994
[TBL] [Abstract][Full Text] [Related]
15. Targeting cell adhesion and homing as strategy to cure Waldenström's macroglobulinemia.
Pals ST; Kersten MJ; Spaargaren M
Best Pract Res Clin Haematol; 2016 Jun; 29(2):161-168. PubMed ID: 27825462
[TBL] [Abstract][Full Text] [Related]
16. Targeting IL-6 receptor reduces IgM levels and tumor growth in Waldenström macroglobulinemia.
Han W; Matissek SJ; Jackson DA; Sklavanitis B; Elsawa SF
Oncotarget; 2019 May; 10(36):3400-3407. PubMed ID: 31164961
[TBL] [Abstract][Full Text] [Related]
17. Single-cell profiles reveal tumor cell heterogeneity and immunosuppressive microenvironment in Waldenström macroglobulinemia.
Sun H; Fang T; Wang T; Yu Z; Gong L; Wei X; Wang H; He Y; Liu L; Yan Y; Sui W; Xu Y; Yi S; Qiu L; Hao M
J Transl Med; 2022 Dec; 20(1):576. PubMed ID: 36494694
[TBL] [Abstract][Full Text] [Related]
18. Jak/Stat pathway in Waldenström's macroglobulinemia.
Hodge LS; Ansell SM
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):112-4. PubMed ID: 21454207
[TBL] [Abstract][Full Text] [Related]
19. Extramedullary Waldenström macroglobulinemia.
Banwait R; Aljawai Y; Cappuccio J; McDiarmid S; Morgan EA; Leblebjian H; Roccaro AM; Laubach J; Castillo JJ; Paba-Prada C; Treon S; Redd R; Weller E; Ghobrial IM
Am J Hematol; 2015 Feb; 90(2):100-4. PubMed ID: 25349134
[TBL] [Abstract][Full Text] [Related]
20. Waldenström Macroglobulinemia: Mechanisms of Disease Progression and Current Therapies.
Boutilier AJ; Huang L; Elsawa SF
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
